ANI PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Ani Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2024.
  • Ani Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 19.4M shares, a 2.76% increase year-over-year.
  • Ani Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 18M shares, a 10.7% increase from 2022.
  • Ani Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 16.3M shares, a 29.1% increase from 2021.
  • Ani Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 12.6M shares, a 5.28% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 19.4M +521K +2.76% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 19.3M +1.63M +9.23% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 19.1M +2.71M +16.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 18M +1.74M +10.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 18.9M +2.58M +15.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 17.7M +1.42M +8.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 16.4M +255K +1.58% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 16.3M +3.66M +29.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 16.3M +4.2M +34.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 16.3M +4.19M +34.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 16.1M +4.13M +34.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 12.6M +632K +5.28% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 12.1M +116K +0.97% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 12.1M +118K +0.99% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 12M +102K +0.86% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 12M +123K +1.04% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-09
Q3 2020 12M +112K +0.94% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 12M +116K +0.98% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 11.9M +155K +1.32% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 11.8M +164K +1.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-15
Q3 2019 11.9M +173K +1.48% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 11.9M +172K +1.47% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 11.7M +158K +1.36% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 11.7M +130K +1.13% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-11
Q3 2018 11.7M +153K +1.32% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 11.7M +133K +1.15% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 11.6M +62K +0.54% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 11.5M +102K +0.89% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 11.6M +88K +0.77% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 11.5M +144K +1.26% Mar 31, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 11.5M +132K +1.16% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 11.4M +75K +0.66% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 11.5M +81K +0.71% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 11.4M +58K +0.51% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 11.4M +69K +0.61% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 11.4M +429K +3.92% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 11.4M +149K +1.33% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 11.3M +111K +0.99% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 11.3M +1.34M +13.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 10.9M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-02
Q3 2014 11.2M +1.76M +18.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 11.2M +10.1M +874% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 9.99M +9.99M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q3 2013 9.48M -13.4M -58.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 1.15M -19M -94.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 0 -116M -100% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 21.8M +5.36M +32.7% Oct 1, 2012 Dec 31, 2012 10-K 2013-02-28
Q3 2012 22.9M +5.51M +31.7% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-08
Q2 2012 20.2M +4.54M +29% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-01
Q1 2012 116M +31.5M +37.2% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-08
Q4 2011 16.4M Oct 1, 2011 Dec 31, 2011 10-K 2013-02-28
Q3 2011 17.4M -53.8M -75.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 15.7M -48.9M -75.8% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-01
Q1 2011 84.8M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q3 2010 71.2M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 64.6M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.